EUDA Health Shrinks Share Count by 95% in Reverse Stock Split

Event summary

  • EUDA Health will implement a 1-for-20 reverse stock split effective March 23, 2026.
  • Outstanding shares will reduce from ~50.3 million to ~2.5 million.
  • Warrant terms will be adjusted proportionally, increasing exercise price to $230.00.
  • Shareholder ownership percentages and voting rights remain unchanged.
  • The company operates in Singapore, Malaysia, and China, focusing on non-invasive healthcare.

The big picture

EUDA Health's reverse stock split is a strategic move to potentially boost share price and attract institutional investors, aligning with broader trends in capital structure optimization. The company operates in a rapidly aging Asian market, positioning itself as a leader in non-invasive and preventive healthcare. This restructuring could signal confidence in long-term growth despite regulatory and competitive challenges in the region.

What we're watching

Market Perception
How the reverse stock split will impact investor sentiment and trading liquidity.
Operational Focus
Whether EUDA can sustain growth in the competitive Asian healthcare market.
Financial Strategy
The pace at which EUDA will deploy capital post-split to support expansion.